Colombia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Colombia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Colombia Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Colombia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Colombian pharmaceutical market has growth potential in Latin America due to qualified human resources, good manufacturing practices (GMP), and quality pharmaceutical products. Colombia’s pharmaceutical market was worth $4.3 billion in 2014, which increased at a Compound Annual Growth Rate (CAGR) of 2.1% to $4.8 billion in 2019 in terms of US dollars. The market value is expected to reach $5.7 billion by 2027. In Latin America, Colombia ranks third in the medical device market, after Brazil and Mexico. The medical device market in Colombia was calculated as $2.3 million in 2019. In 2019, Colombia Productiva released the pharmaceutical industry business plan for providing a roadmap for the growth of the pharma industry by 2032. This plan aims for Colombia to be a leader in the manufacturing and distribution of medicines to meet local needs based on public health needs, and serve as a major distributor of drugs across the South American continent.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Colombia, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Bayer, Merck, GlaxoSmithKline (GSK), Genomma Lab, and Biopas.
• Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Fresenius, and Siemens Healthineers.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Colombian healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Colombian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Colombian healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership